ArticleHeart rhythm O22026
Impact of radiofrequency power settings on acute mitral isthmus ablation success with concomitant vein of Marshall ethanol infusion.
Article in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Achieving acute bidirectional block across the mitral isthmus (MI) remains technically challenging owing to the complex architecture of the left atrial (LA) inferolateral wall and the presence of epicardial connections via the coronary sinus (CS) and vein of Marshall. Ethanol infusion into the vein of Marshall (VOM-EI) has been shown to facilitate acute MI line completion, but the influence of high-power short-duration (HPSD) radiofrequency (RF) settings in this context has not been fully evaluated. Objectives: This study aimed to assess the impact of 2 RF power strategies (50 W vs 35 W) on procedural efficacy and safety of MI ablation performed with adjunctive VOM-EI in an exploratory randomized study. Methods: 71 patients planned for LA linear ablation for persistent atrial fibrillation were randomly assigned to receive either 50 W (HPSD; n = 37) or 35 W (conventional; n = 34). VOM-EI was the first step preceding LA RF. Procedural metrics, acute MI bidirectional block, and safety were analyzed. Results: Mitral RF delivery was performed with an ablation index target of 450-550. HPSD ablation significantly reduced the number of endocardial MI applications (11 ± 7.1 vs 18.8 ± 13; Conclusion: In this exploratory randomized study, a 50-W ablation strategy during MI ablation with adjunctive VOM-EI reduced the number of RF applications and increased first-pass block without increasing complications. These findings suggest that higher-power delivery may improve procedural efficiency during MI ablation. Larger studies are needed to determine whether these differences translate into improved long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.